Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

Summary

The purpose of this study is to explore the safety of NK cells from Sibship in patients with recurrent hepatocellular carcinoma after liver transplantation.

Timeline

Start

2014-10

Primary completion

2018-06

Completion

2018-06

Publications

• Yang F, Gong Y, Zheng X, Ni B, Lu J, Chen X, Cheng J, Li P, Du C, Chen Y, Zhang Y, Yi S, Wang G, Zhang Q, Yang Y, Chen W. NK cell infusion is well-tolerated and shows preliminary efficacy in patients with recurrent hepatocellular carcinoma post-liver transplantation : a phase I trial. J Transl Med. 2026 Jan 24;24(1):261. doi: 10.1186/s12967-026-07725-x.

Drugs

Indications